Tazact 1.125 gm Injection
Marketer
Cipla Ltd
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Tazact 1.125 gm Injection
Tazact 1.125-gram injection combines two antibiotics to combat diverse bacterial infections by eliminating harmful microorganisms. Administration should only be performed by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity, adhering to their prescribed regimen is crucial. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, inform your doctor about any antibiotic allergies, kidney, or liver conditions; adjustments to dosage or alternative medications may be necessary. Under medical guidance, Tazact 1.125-gram injection is generally considered safe for use during pregnancy and breastfeeding.
Uses of Tazact 1.125 gm Injection
Infections caused by bacteria
Major Benefits of Tazact 1.125 gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tazact 1.125 gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazact 1.125 gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazact 1.125 gm Injection works:
The injectable formulation Tazact 1.125 gm combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol and Tazact 1.125 gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tazact, 1.125 grams, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Tazact 1.125 gm Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Tazact 1.125 gm Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Tazact 1.125 gm Injection cautiously. Dosage modification for Tazact 1.125 gm Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of a 1.125 gm Tazact injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Tazact 1.125 gm Injection :
Omit a Tazact 1.125 gm Injection dose? Seek medical advice immediately.
Facts to Know About Tazact 1.125 gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |







